XML 24 R12.htm IDEA: XBRL DOCUMENT

Marketable EQUITY Securities

3 Months Ended

Mar. 31, 2023

6. Marketable EQUITY Securities

Marketable equity securities with readily determinable market prices consisted of the following as of March 31, 2023 and December 31, 2022:

Schedule of marketable securities
	Marketable equity securities at March 31, 2023
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	7,086,000	$	55,000	$	(5,773,000	)	$	1,368,000

	Marketable equity securities at December 31, 2022
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	10,271,000	$	383,000	$	(4,064,000	)	$	6,590,000

The Company’s investment in marketable equity securities is revalued on each balance sheet date.